Financhill
Back

Becton Dickinson & Quote, Financials, Valuation and Earnings

Sell
46

BDX
Becton Dickinson &

Last Price:
231.92
Seasonality Move:
0.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Becton Dickinson & Price Quote

$231.92
-0.05 (2.27%)
(Updated: June 1, 2024 at 6:08 AM ET)

Becton Dickinson & Key Stats

Sell
46
Becton Dickinson & (BDX) is a Sell

Day range:
$226.32 - $232.21
52-week range:
$224.00 - $287.32
Dividend yield:
1.6%
P/E ratio:
46.96
P/S ratio:
3.42
P/B ratio:
2.61%

Volume:
4.7M
Avg. volume:
1.6M
1-year change:
-4.05%
Market cap:
$67B
Revenue:
$19.4B
EPS:
$4.54

How Much Does Becton Dickinson & Make?

Is Becton Dickinson & Growing As A Company?

  • What Is Becton Dickinson &'s Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Becton Dickinson &'s EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.21%

Becton Dickinson & Stock Price Performance

What Is Becton Dickinson & 52-Week High & Low?

Becton Dickinson & Price To Free Cash Flow

Is It Risky To Buy Becton Dickinson &?

Is Becton Dickinson & Cash Flow Positive?

  • What Is BDX Cash Flow From Operations?
    Cash flow from operations (TTM) is $3.8B
  • What Is Becton Dickinson &’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.9B
  • What Is Becton Dickinson &’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.5B

Becton Dickinson & Return On Invested Capital

  • Is Management Doing A Good Job?
    BDX return on invested capital is 3.12%
  • What Is Becton Dickinson & Return On Assets?
    ROA measures how assets are converting to revenues and is 2.5%
  • What Is BDX Return On Equity?
    ROE is a measure of profitability and is 5.19%

Becton Dickinson & Earnings Date & Stock Price

Becton Dickinson & Competitors

  • Who Are Becton Dickinson &'s Competitors?
    Below is a list of companies who compete with Becton Dickinson & or are related in some way:
    • Abbott Laboratories (ABT)
    • AngioDynamics Inc (ANGO)
    • Intuitive Surgical Inc (ISRG)
    • LeMaitre Vascular Inc (LMAT)
    • Merit Medical Systems Inc (MMSI)

Becton Dickinson & Dividend Yield

Becton Dickinson & Analyst Estimates

YoY Growth Past Surprise
EPS: 20.92% 6.77%
Revenue: 4.65% 0.15%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 278.69
Upside from Last Price: 20.14%

Major Shareholders

  • How many BDX shares are owned by institutional investors?
    390.9M BDX shares are owned by institutional investors
  • How many BDX shares are owned by insiders?
    1.5M BDX shares are owned by insiders